COPD trials in New Zealand

In New Zealand 8 Also abroad 559

8 trials · From ClinicalTrials.gov, checked 11 November 2026. Ask the study team whether a trial fits you.

Phase 3Taking people
Efficacy, Safety, and Tolerability Study of Lunsekimig Compared With Placebo in Adult Participants With Inadequately Controlled Chronic Obstructive Pulmonary Disease (COPD), Characterized by an Eosinophilic Phenotype
Where
Auckland, Christchurch, Ebdentown
Age
40 years to 80 years
People
942 worldwide
Run by
Sanofi
See details and how to joinNCT07190222 · EU 2024-518213-25-00
Phase 3Taking people
A Study to Investigate the Efficacy and Safety of Tezepelumab in Adult Participants With Moderate to Very Severe COPD (D5241C00007)
Where
Auckland, Hamilton West, Tauranga
Age
40 years to 80 years
People
990 worldwide
Run by
AstraZeneca
See details and how to joinNCT06878261 · EU 2024-517457-27-00
Phase 3Taking people
Depemokimab as an Extended Treatment Duration Biologic in Adults With Chronic Obstructive Pulmonary Disease (COPD) and Type 2 Inflammation (ENDURA-2)
Where
Auckland, Christchurch, Ebdentown, Hamilton, Rotorua, Takapuna
Age
40 years to 80 years
People
961 worldwide
Run by
GlaxoSmithKline
See details and how to joinNCT06961214 · EU 2024-520417-41-00
Phase 3Taking people
eValuating the Efficacy and Safety of InitiatinG depemokImab earLy therApy iN Chronic Obstructive Pulmonary Disorder (COPD) With Type 2 Inflammation
Where
Ebdentown, Rotorua
Age
40 years to 75 years
People
1,196 worldwide
Run by
GlaxoSmithKline
See details and how to joinNCT07177339 · EU 2025-521108-23-00
Phase 1Taking people
A Study of BBT002 in Healthy Volunteers (HVs) and in Adult Patients With Chronic Obstructive Pulmonary Disease (COPD) or Chronic Rhiosininusitis With Nasal Polyps (CRSwNP)
Where
Pukekohe, Rotorua, Wellington
Age
18 years to 80 years
People
286 worldwide
Run by
Bambusa Therapeutics
See details and how to joinNCT06944925 · EU 2025-523142-28-00
Phase 3Enrolling by invitation
Long Term Safety of Alpha1-Proteinase Inhibitor in Subjects With Alpha1 Antitrypsin Deficiency
Where
Auckland, Christchurch, Hamilton
Age
20 years to 72 years
People
290 worldwide
Run by
Grifols Therapeutics LLC
See details and how to joinNCT02796937
No phaseNot yet taking people in New Zealand
The Effect of Mask Design on Ventilation Parameters in COPD and OHS Patients on Long-term Home Non-invasive Ventilation. An Experimental Study.
Where
Auckland
Age
18 years and over
People
20
Run by
Fisher and Paykel Healthcare
See details and how to joinNCT06972589
No phaseTaking people
Assessment of Breathing Pattern During NIV
Where
Auckland
Age
18 years and over
People
40
Run by
Fisher and Paykel Healthcare
See details and how to joinNCT06682286